Skip to main content
    A

    AN2 Therapeutics Inc (ANTX)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $4.47
    -0.08 (-1.76%)

    Market Cap: $172.64M

    Last updated: Nov 17, 2026 at 11:04 AM ET

    AN2 Therapeutics Inc (ANTX) Earnings: Report Dates and Results

    Updated Nov 9, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    AN2 Therapeutics (ANTX) is expected to report earnings on Mar 15, 2027. In the quarter ended Sep 30, 2026, AN2 Therapeutics reported EPS of -$0.17, above the -$0.20 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    58%(11/19)
    Avg Surprise
    -25.22%
    Streak
    2 Q

    Upcoming Estimates

    Reports Mar 15, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus-$0.24
    Range-$0.25 - -$0.22
    4 analysts
    Revenue Consensus
    N/A
    RangeN/A
    4 analysts
    Reports May 10, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus-$0.19
    Range-$0.19 - -$0.19
    1 analysts
    EPS RevisionsNo revisions (30d)
    EPS Estimate DriftChange to current
    90d ago$0.00n/a
    60d ago-$0.21+9.5%
    30d ago-$0.21+9.5%
    7d ago-$0.21+9.5%
    Current-$0.19
    Revenue Consensus
    N/A
    RangeN/A
    1 analysts

    Next Report

    ANTX has an expected report date of Mar 15, 2027.

    Earnings History

    Of the 19 quarters below that had an estimate, ANTX beat 11 and missed 8. The widest gap in the table came in the quarter ended Mar 31, 2022, when EPS landed 484.31% below the estimate.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReported
    Sep 30, 2026-$0.17-$0.20-$0.20 - -$0.20+15.00%BeatN/A2N/ANov 9, 2026
    Jun 30, 2026-$0.18-$0.24-$0.25 - -$0.23+25.00%BeatN/A21 up, 0 downAug 11, 2026
    Mar 31, 2026-$0.29-$0.23-$0.23 - -$0.23-26.09%MissN/A11 up, 0 downMay 11, 2026
    Dec 31, 2025-$0.29-$0.24-$0.24 - -$0.24-20.83%MissN/A10 up, 1 downMar 17, 2026
    Sep 30, 2025-$0.31-$0.22-$0.23 - -$0.21-40.91%MissN/A20 up, 0 downNov 12, 2025
    Jun 30, 2025-$0.21-$0.31-$0.31 - -$0.31+32.26%BeatN/A11 up, 0 downAug 12, 2025
    Mar 31, 2025-$0.35-$0.27-$0.27 - -$0.25-29.63%MissN/A21 up, 0 downMay 13, 2025
    Dec 31, 2024-$0.25-$0.27N/A+7.41%BeatN/A10 up, 0 downMar 25, 2025
    Sep 30, 2024-$0.35-$0.39-$0.42 - -$0.32+10.26%BeatN/A30 up, 0 downNov 13, 2024
    Jun 30, 2024-$0.48-$0.59-$0.65 - -$0.51+18.64%BeatN/A40 up, 0 downAug 13, 2024
    Mar 31, 2024-$0.56-$0.62-$0.67 - -$0.56+9.68%BeatN/A40 up, 0 downMay 14, 2024
    Dec 31, 2023-$0.57-$0.75-$0.83 - -$0.69+24.00%BeatN/A40 up, 0 downMar 28, 2024
    Sep 30, 2023-$0.65-$0.63-$0.75 - -$0.56-3.17%MissN/A32 up, 0 downNov 9, 2023
    Jun 30, 2023-$0.81-$0.85-$0.91 - -$0.80+4.71%BeatN/A30 up, 0 downAug 10, 2023
    Mar 31, 2023-$0.79-$0.68-$0.69 - -$0.66-16.18%MissN/A30 up, 0 downMay 11, 2023
    Dec 31, 2022-$0.61-$0.65-$0.68 - -$0.61+6.15%BeatN/A30 up, 0 downMar 29, 2023
    Sep 30, 2022-$0.59-$0.60-$0.60 - -$0.58+1.67%BeatN/A30 up, 0 downNov 9, 2022
    Jun 30, 2022-$0.53-$0.47-$0.48 - -$0.42-12.77%MissN/A30 up, 0 downAug 11, 2022
    Mar 31, 2022-$2.98-$0.51N/A-484.31%MissN/AN/AN/AMay 10, 2022
    Dec 31, 2021Not reportedN/AN/AN/ANot reportedN/AN/AN/AMar 28, 2022
    Last 20 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$1.16, after -$1.64 the year before. It was -$4.71 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years below with reported EPS.

    Fiscal year endedEPSChange
    Dec 31, 2025-$1.16N/A
    Dec 31, 2024-$1.64N/A
    Dec 31, 2023-$2.82N/A
    Dec 31, 2022-$4.71N/A
    Dec 31, 2021Not reportedN/A

    Frequently Asked Questions About ANTX

    When is AN2 Therapeutics's next earnings date?

    AN2 Therapeutics's next earnings report is expected for Mar 15, 2027.

    Did ANTX beat earnings estimates last quarter?

    Yes. AN2 Therapeutics reported EPS of -$0.17 for the quarter ended Sep 30, 2026, above the -$0.20 estimate, a 15.00% surprise.

    What EPS do analysts expect from ANTX next quarter?

    The consensus EPS estimate for AN2 Therapeutics for the quarter ending Dec 31, 2026 is -$0.24 from 4 analysts, with estimates from -$0.25 to -$0.22.

    How often does ANTX beat earnings estimates?

    AN2 Therapeutics beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -4.72%.